These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1802286)

  • 1. Porcine factor VIIIC in the management of patients with factor VIII inhibitors.
    Hay CR; Bolton-Maggs P
    Transfus Med Rev; 1991 Oct; 5(4):293-9. PubMed ID: 1802286
    [No Abstract]   [Full Text] [Related]  

  • 2. [Porcine factor VIII].
    De Juan MJ; Montoro JB; Tusell JM
    Sangre (Barc); 1991 Jun; 36(3):217-20. PubMed ID: 1948542
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of porcine factor VIII (Hyate C).
    Hermans C; Owens D; Longo G; Morfini M; Lee CA
    Thromb Haemost; 2002 Feb; 87(2):352-3. PubMed ID: 11858504
    [No Abstract]   [Full Text] [Related]  

  • 4. Porcine factor VIII provides clinical benefit to patients with high levels of inhibitors to human and porcine factor VIII.
    Gribble J; Garvey MB
    Haemophilia; 2000 Sep; 6(5):482-5. PubMed ID: 11012689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII inhibitors.
    Lollar P; Healey JF; Barrow RT; Parker ET
    Adv Exp Med Biol; 2001; 489():65-73. PubMed ID: 11554592
    [No Abstract]   [Full Text] [Related]  

  • 6. Porcine factor VIII therapy in patients with factor VIII inhibitors.
    Hay C; Lozier JN
    Adv Exp Med Biol; 1995; 386():143-51. PubMed ID: 8851022
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.
    Lozier JN; Santagostino E; Kasper CK; Teitel JM; Hay CR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of anti-human and anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A. A French Multicentric Study.
    Fiks-Sigaud M; Bendelac L; Parquet A; Verroust F; Torchet MF; Berthier AM; Fressinaud E; Guerois C; Aillaud MF; Boneu B
    Vox Sang; 1993; 64(4):210-4. PubMed ID: 8517049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of hemophilia patients with inhibitors.
    Nilsson IM
    Transfus Med Rev; 1992 Oct; 6(4):285-93. PubMed ID: 1421831
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII.
    Koshihara K; Qian J; Lollar P; Hoyer LW
    Blood; 1995 Sep; 86(6):2183-90. PubMed ID: 7662967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immune tolerance in patients with hemophilia A and inhibitors treated with porcine VIIIC by home therapy.
    Hay CR; Laurian Y; Verroust F; Preston FE; Kernoff PB
    Blood; 1990 Sep; 76(5):882-6. PubMed ID: 2118396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of hemophilia A treatment: factor VIII inhibitors.
    Kasper CK
    Ann N Y Acad Sci; 1991; 614():97-105. PubMed ID: 1902643
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.
    Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB
    Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity.
    Oldenburg J; Lacroix-Desmazes S; Lillicrap D
    Haematologica; 2015 Feb; 100(2):149-56. PubMed ID: 25638804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of factor VIII inhibitors: evolution and current status.
    Bloom AL
    Haemostasis; 1992; 22(5):268-75. PubMed ID: 1478538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evidence behind inhibitor treatment with porcine factor VIII.
    Lee CA
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():5-8. PubMed ID: 12214138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience.
    Brettler DB; Forsberg AD; Levine PH; Aledort LM; Hilgartner MW; Kasper CK; Lusher JM; McMillan C; Roberts H
    Arch Intern Med; 1989 Jun; 149(6):1381-5. PubMed ID: 2499293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of factor VIII inhibitors.
    Kasper CK
    Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.
    Kaveri SV
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):55-7. PubMed ID: 19153680
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of porcine factor VIII in the management of unexpected bleeding episodes.
    Aledort LM
    Haemophilia; 2002 Jan; 8 Suppl 1():17-9; discussion 28-32. PubMed ID: 11882078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.